EcoDrugPlus

Ensembl ID : ENSATEG00000008511
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSATEG00000013482
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSATEG00000014458
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSATEG00000014692
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSATEG00000029437
Gene Symbol: -
1 Cross references
372 Possible Orthologues:

Ensembl ID : ENSATEG00000014939
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSATEG00000014963
Gene Symbol: -
Cross references: -
301 Possible Orthologues:

Ensembl ID : ENSATEG00000027783
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSATEG00000015858
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSATEG00000016468
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSATEG00000027675
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSATEG00000016833
Gene Symbol: -
Cross references: -
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).